3,5-diiodothyronine has been researched along with palmitic acid in 1 studies
| Studies (3,5-diiodothyronine) | Trials (3,5-diiodothyronine) | Recent Studies (post-2010) (3,5-diiodothyronine) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
|---|---|---|---|---|---|
| 126 | 1 | 58 | 6,794 | 159 | 2,458 |
| Protein | Taxonomy | 3,5-diiodothyronine (IC50) | palmitic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 | |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
| Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canesi, L; Compalati, AD; Damonte, G; Gallo, G; Goglia, F; Grasselli, E; Salis, A; Vergani, L; Voci, A | 1 |
1 other study(ies) available for 3,5-diiodothyronine and palmitic acid
| Article | Year |
|---|---|
3,5-diiodo-L-thyronine modifies the lipid droplet composition in a model of hepatosteatosis.
Topics: Animals; Cell Line, Tumor; Diiodothyronines; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fatty Liver; Intracellular Signaling Peptides and Proteins; Lipase; Lipid Metabolism; Mitochondria, Liver; Models, Biological; Muscle Proteins; Oleic Acid; Oxidation-Reduction; Palmitic Acid; Perilipin-5; Rats | 2014 |